Biotech Values

[DewDiligence]

GVPB’s PR’s continue to provide comic relief! This one was
cleverly timed for release on a weekend. Read down to the
end and you’ll see the germ of yet another “clarifying” PR.

http://finance.yahoo.com/news/GENova-issues-clarifying-prnews-3716219142.html?x=0&.v=2

›GENova Issues Clarifying Press Release

Saturday September 12, 2009, 3:17 pm EDT

NEW YORK, Sept. 12 /PRNewswire-FirstCall/ - GENova Biotherapeutics Inc. ("GENova") clarified today information disseminated in previous press releases regarding the patents currently in GENova's IP portfolio.

GENova owns the rights to a range of drug targets and has filed patent application for all of them. The patents have not yet been approved and are therefore considered 'patents-pending'. It has been brought to GENova's attention that previous releases were not entirely clear on this issue and may have been misconstrued by some investors.

Any statements made prior to this announcement which stated or implied that patents have been granted are incorrect and should not be relied upon in making investment decisions. [LMAO!]

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. [We’ve already laughed at this—no further discussion necessary.]

The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these drug product candidates to Big Pharmaceutical and Biotechnology companies. [I see yet another “clarification” PR being needed to deal with this sentence insofar as GVPB has not out-licensed anything to anybody!]